Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 4Tumor-Agnostic 2Lymphoid 2Dermatologic 2Gynecologic 1Genitourinary 1CNS 1

Conditions

Skin Neoplasms 1Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Cyclophosphamide 170Rituximab 143Specimen Handling 82venetoclax 79fludarabine 78Vincristine 69obinutuzumab 67Doxorubicin 66Prednisone 65Biopsy 64Magnetic Resonance Spectroscopy 62zanubrutinib 52Lenalidomide 52Dexamethasone 49Methotrexate 43Cytarabine 43blinatumomab 40acalabrutinib 37Immunotherapy, Adoptive 37Bendamustine Hydrochloride 37Etoposide 32fludarabine phosphate 31ibrutinib 28glofitamab 28polatuzumab vedotin 26pirtobrutinib 24orelabrutinib 24Gemcitabine 23Injections 21Mercaptopurine 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Hematologic Tests × Lymphoid × Clear all
NCT04053439 2025-07-08

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Sunnybrook Health Sciences Centre

Recruiting
188 enrolled
Lymphoid

Lymphoma

NCT04904146 2025-03-10

BIO-MUSE

Lund University Hospital

Recruiting
120 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Skin Neoplasms, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡